Smoking is highly likely to worsen the severity of COVID-19 and the risk of dying with the infection, finds a large study led by researchers from the University of Oxford and published online in the respiratory journal Thorax.
We are delighted to announce that Jamie Hartmann-Boyce, James Sheppard and Sarah Tonkin-Crine have been awarded the title of Associate Professor, in recognition of their research achievements, contribution to teaching, and contribution to the general work of the department and the wider Medical Sciences Division.
Professor Julia Hippisley-Cox and her team have been Highly Commended in the \u2018Best use of technology in Patient Safety\u2019 category for the QCovid risk calculator at this year\u2019s Health Service Journal Patient Safety Awards.
New algorithm predicts those most at risk of serious Covid-19 outcomes from 14 or more days after second vaccination dose, when substantial immunity is expected to have developed Authors hope this new risk tool will allow those who perceive risk to be high to make more informed decisions regarding shielding and potentially inform policy and clinical decisions on booster vaccine doses and monoclonal antibodies
Published this week is the fourth update of the Cochrane review of \u2018Electronic cigarettes for smoking cessation\u2019, and the second since it switched to a living review format in October 2020. This review brings together the most up to date research findings on the effect and safety of using electronic cigarettes to help people to stop smoking.
Congratulations to Michael Tringale, who recently completed the MSc in Evidence-Based Health Care, and Claire Duddy, who recently completed the MSc in EBHC Systematic Reviews, as they are both awarded this year's EBHC Dissertation Prize for outstanding dissertation.
The Bennett Institute for Applied Data Science at the University of Oxford has been established to pioneer the better use of data, evidence and digital tools in healthcare and policy, optimizing the impact of interventions to achieve improved outcomes. The Institute has been made possible due to a generous donation from The Peter Bennett Foundation
The Nuffield Department of Primary Care Health Sciences is co-leading on a recently announced nation-wide collaborative project to evaluate a new technology which aims to detect early signs of multiple types of cancer.
The research, led by researchers at the Nuffield Department of Primary Care Health Sciences, is highlighted in a special collection of studies that focus on early cancer detection, hailed by the Editors as \u201ccutting edge, and potentially scalable, innovations that have the potential to inform research, policy, and clinical cancer management.\u201d
The Nuffield Department of Primary Care Health Sciences is delighted to announce that it has been awarded \u00a3557,674 to investigate how families are managing to cope with \u2018long covid\u2019 and to understand how best they can be supported.
The results, from within the OpenSAFELY platform, are based on electronic health records for more than 17 million people registered with a general practice in England linked to hospital admission and mortality data.
The QCovid\u00ae-powered COVID-19 Population Risk Assessment, developed by a cross-organisational team and rolled across NHS England, has won the Florence Nightingale Award for Excellence in Healthcare Data Analytics.
Statins are associated with a small increased risk of side effects in patients without a history of heart disease, but these effects are mild compared with the potential benefits of treatment in preventing major cardiovascular events, finds a study led by Oxford University researchers.
The PRINCIPLE trial has been highly commended at the Health Data Research UK Awards for the way in which patient data is utilised so participants are contacted about the trial soon after receiving a positive test result.
Good data on Long COVID will be crucial for research into the prevalence of Long COVID, its causes and consequences, and to plan services effectively, say researchers following their analysis of 96% of electronic healthcare records in England using the OpenSAFELY platform.
From today, ivermectin is being investigated in the UK as part of the Platform Randomised Trial of Treatments in the Community for Epidemic and Pandemic Illnesses (PRINCIPLE), the world\u2019s largest clinical trial of possible COVID-19 treatments for recovery at home and in other non-hospital settings.
There are higher proportions of ethnic minority children in England testing positive for COVID-19 than white children, with Asian children more likely to be admitted to hospital with the illness, finds an observational analysis of 2.6 million healthcare records led by Oxford University researchers.
![\"A](\"https://www.phc.ox.ac.uk/news/smoking-associated-with-higher-risk-of-death-and-hospitalisation-with-covid-19/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n